Arrowhead Pharmaceuticals
ARWR
#2189
Rank
A$12.58 B
Marketcap
A$89.85
Share price
-2.07%
Change (1 day)
360.19%
Change (1 year)

Earnings for Arrowhead Pharmaceuticals (ARWR)

Earnings in 2025 (TTM): A$0.55 Billion

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current earnings are A$1.09 Billion. , an increase over its 2024 earnings that were of -A$0.85 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Arrowhead Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025 A$0.48 B-157.5%
2024 -A$0.85 Billion112.45%
2023 -A$0.4 Billion87.79%
2022 -A$0.22 Billion-20.1%
2021 -A$0.27 Billion67.59%
2020 -A$0.16 Billion-347.53%
2019 A$63.93 M-245.59%
2018 -A$43.92 Million-13.17%
2017 -A$50.58 Million-52.28%
2016 -A$0.11 Billion-16.57%
2015 -A$0.13 Billion30.32%
2014 -A$97.49 Million171.62%
2013 -A$35.9 Million16.56%
2012 -A$30.8 Million107.53%
2011 -A$14.84 Million
2008 -A$52.27 Million-8.07%
2007 -A$56.86 Million70.37%
2006 -A$33.37 Million122.51%
2005 -A$15 Million147.41%
2004 -A$6.07 Million2002.28%
2003 -A$0.29 Million-85.61%
2002 -A$2.01 Million1371.97%
2001 -A$0.14 Million-13.45%
2000 -A$0.16 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$47.26 B 9,621.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-A$3.89 Billion-899.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$0.23 B-52.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-A$0.17 Billion-134.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$0.81 B 66.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
-A$0.16 Billion-131.32%๐Ÿ‡บ๐Ÿ‡ธ USA